INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-45 Cr | ₹-32 Cr | ₹-30 Cr | ₹-52 Cr | ₹-60 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-45 Cr |
| Mar2024 | ₹-32 Cr |
| Mar2023 | ₹-30 Cr |
| Mar2022 | ₹-52 Cr |
| Mar2021 | ₹-60 Cr |
How is Deferred Tax Assets / Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-45 Cr | Negative | |
| Mar2024 | ₹-32 Cr | Negative | |
| Mar2023 | ₹-30 Cr | Negative | |
| Mar2022 | ₹-52 Cr | Negative | |
| Mar2021 | ₹-60 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹1,417.2 Cr | 3.5% | 17.7% | 71.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 3.5% |
17.7% |
71.4% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses